YS Biopharma (YSB) Institutional Ownership

Current Institutional Ownership Percentage: 52.64%
Number of Institutional Buyers (last 12 months): 2
Total Institutional Inflows (last 12 months): $254.53K

Number of Institutional Sellers (last 12 months): 0

Get YSB Insider Trade Alerts

Want to know when executives and insiders are buying or selling YS Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

YSB Institutional Buying and Selling by Quarter

Ad Porter & Company

The most serious warning of my career

With the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the financial world in two the moment the polls close. I predict they could see investment losses of 50% (or more) in the weeks following the presidential election.

Click here now to grab your seat now.

YS Biopharma Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/5/2024	Ovata Capital Management Ltd	150,000	$153K	0.1%	N/A	0.161%
2/14/2024	Superstring Capital Management LP	307,920	$166K	0.1%	N/A	0.331%
9/21/2023	Barclays PLC	108,894	$150K	0.0%	N/A	0.423%
8/14/2023	Prelude Capital Management LLC	32,200	$44K	0.0%	N/A	0.125%
5/16/2023	Snow Lake Management LP	1,811,942	$2.90M	1.7%	N/A	7.037%
5/16/2023	Hhlr Advisors LTD.	751,790	$1.20M	0.0%	N/A	2.920%
5/15/2023	RTW Investments LP	341,090	$546K	0.0%	N/A	1.325%
5/11/2023	FIL Ltd	2,718,499	$4.35M	0.0%	N/A	10.557%
5/10/2023	Valliance Asset Management Ltd	1,607,175	$2.57M	4.6%	N/A	6.241%

(Data available from 1/1/2016 forward)

YSB Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of YSB shares?: During the previous two years, 9 institutional investors and hedge funds held shares of YS Biopharma. The most heavily invested institutionals were FIL Ltd ($4.35M), Snow Lake Management LP ($2.90M), Valliance Asset Management Ltd ($2.57M), Hhlr Advisors LTD. ($1.20M), RTW Investments LP ($546K), Superstring Capital Management LP ($166K), and Ovata Capital Management Ltd ($153K).Learn more on YSB's institutional investors.
What percentage of YS Biopharma stock is owned by institutional investors?: 52.64% of YS Biopharma stock is owned by institutional investors. Learn more on YSB's institutional investor holdings.
Which institutional investors have been buying YS Biopharma stock?: Of the 9 institutional investors that purchased YS Biopharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FIL Ltd ($2.72M), Snow Lake Management LP ($1.81M), Valliance Asset Management Ltd ($1.61M), Hhlr Advisors LTD. ($751.79K), RTW Investments LP ($341.09K), Superstring Capital Management LP ($307.92K), and Ovata Capital Management Ltd ($150K).

How much institutional buying is happening at YS Biopharma?: Institutional investors have bought a total of 7,829,510 shares in the last 24 months. This purchase volume represents approximately $12.02M in transactions.

Related Companies: